MAP2K7 and neoplasm: It has dual anti-tumor effects: it can directly inhibit tumor cell proliferation by blocking the cell signaling pathway mediated by RAF/MEK/ERK, and indirectly inhibit tumor cell growth by blocking the formation of tumor neovascularization through inhibiting VEGFR and platelet-derived growth factor (PDGF) receptors (54).